solvent is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-12-18. Numbers and descriptions here follow the published literature rather than marketing material.
Aseptic technique matters because aqueous peptide solutions can support microbial growth. Sterile solvents, clean workspaces, and sterile filtration can reduce contamination. The choice of filter material and pore size must avoid peptide loss through adsorption, especially for hydrophobic or low-concentration samples. Visual inspection for particles, turbidity, or color change provides a simple initial check, but it cannot confirm identity or purity. Analytical methods such as reversed-phase high-performance liquid chromatography and mass spectrometry are used to verify composition and detect degradation products.
Documentation supports reproducibility and traceability. Records often include lot number, solvent composition, final concentration, preparation date, and storage location. Such details help distinguish procedural variation from actual sample instability. Questions remain about how best to predict long-term stability from short-term accelerated studies, because peptide degradation pathways differ widely. For many peptides, the relationship between in vitro solution stability and biological behavior is incompletely understood and is an active area of research.
Reconstitution is the process of adding a liquid to a lyophilized peptide so that the dried material dissolves into solution. Lyophilization removes water from a frozen peptide preparation under reduced pressure, leaving a porous solid or powder. The dried form often has greater long-term stability than a liquid because hydrolysis and oxidation are slowed. In laboratory work, reconstitution is usually the first step before dilution, analysis, or further experiments. The result is a stock solution whose concentration depends on the volume of solvent added and the amount of peptide in the vial.
Solvent choice depends on the peptide's sequence, charge, and solubility profile. Sterile water is common for freely soluble peptides, while aqueous buffers or dilute acid or base may be needed for others. Some sequences contain hydrophobic regions that resist water alone and require a small amount of organic co-solvent. The solvent's pH can affect charge state, aggregation, and stability. Because peptides vary widely, no single universal reconstitution liquid exists, and suppliers often provide a recommended solvent based on testing of a specific lot or sequence.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature (lyophilized) | -20 °C or lower | Desiccant and sealed container limit moisture |
| Typical storage temperature (reconstituted) | 2-8 °C short term; frozen for longer | Freeze-thaw cycles may damage peptide |
| Appearance of solution | Clear to slightly opalescent | Turbidity or particles suggest aggregation or contamination |
| Identity method | Mass spectrometry | Confirms molecular mass and detects modifications |
| Purity method | Reversed-phase HPLC | Separates peptide from related impurities |
Solvent selection depends on the peptide's charge, hydrophobicity, and intended application. Many lyophilized peptides dissolve readily in water, while others require a small amount of a miscible organic solvent, a dilute acid, or a dilute base before aqueous dilution. A buffer may be used when a stable pH range is known, but adding buffer salts can also promote aggregation or precipitation. Dissolution should be observed rather than assumed, because a clear solution does not prove that the peptide is monomeric or fully active. The order of solvent addition and the final volume matter for achieving the intended concentration.
Once reconstituted, a peptide solution is generally less stable than the dry powder. Hydrolysis, oxidation, aggregation, and microbial growth can change the preparation over time, so storage temperature and duration are practical concerns. Dividing a solution into single-use aliquots before freezing can reduce repeated freeze-thaw cycles, which may otherwise cause precipitation or loss of activity. The optimal storage conditions vary by peptide, and no single rule applies to all sequences. Records of solvent, concentration, date, and storage history help maintain traceability. Studies often report stability under defined conditions rather than universal shelf lives.
Reconstitution is the process of dissolving a lyophilized peptide powder in a suitable liquid to produce a solution for laboratory or clinical use. The dry powder is typically a porous cake or fluffy solid formed by freeze-drying an aqueous or mixed-solvent preparation. Adding solvent restores the peptide to a dissolved state, but the result is not necessarily identical to the original pre-lyophilization solution. Factors such as pH, ionic strength, temperature, and the peptide's sequence influence how completely and quickly dissolution occurs. The term is distinct from dilution, which lowers concentration without changing the physical state of an already dissolved material.
After a peptide solution is prepared, its handling conditions influence how long it remains suitable for use. Solutions are typically separated into small portions to avoid repeated freeze-thaw cycles, which can promote aggregation or precipitation. Containers are chosen to minimize adsorption, especially for peptides that are hydrophobic or present at low concentration. Some laboratories use low-binding plastic tubes or add a carrier protein, although carrier addition can interfere with later analysis. Records usually note the solvent, date, and storage temperature for traceability.
Storage stability of a reconstituted peptide depends on concentration, pH, buffer composition, and the presence of oxygen or microbial contaminants. Short-term storage is often at refrigerated temperatures, while longer-term storage may use freezing at -20 °C or -80 °C. Repeated warming and cooling can cause losses through adsorption or aggregation, so aliquots are preferred. Light-sensitive peptides require protection from ambient light. Sterile filtration may be used when microbial control is needed, but filters can adsorb peptides and reduce recovery.
Quality control after reconstitution usually includes visual inspection and instrumental analysis. A clear, particle-free solution is generally expected, but color and clarity can vary with sequence and buffer. Chromatographic separation can detect degradation products, while mass confirmation verifies molecular identity. pH measurement and osmolality checks may be relevant for certain applications. Documentation of lot number, solvent, and storage history supports reproducibility and helps distinguish preparation artifacts from sample degradation. Temperature logs and freeze-thaw counts add further context when results are reviewed.
After reconstitution, the peptide solution is less stable than the dried powder because water enables hydrolysis, oxidation, and microbial growth. Storage temperature, pH, buffer composition, and container material all affect how long the solution remains usable. Many peptides are kept at 2–8 °C for short-term work, while frozen aliquots at −20 °C or below are used for longer intervals. Repeated freeze-thaw cycles can cause aggregation or precipitation. The choice of storage condition should be based on stability data for the specific peptide.
Quality checks after reconstitution include visual inspection, pH measurement, and analytical methods such as reversed-phase high-performance liquid chromatography. These tests can detect insoluble material, degradation products, and changes in concentration. Mass spectrometry is often used to confirm molecular identity when the peptide sequence is known. Because a clear solution can still contain aggregates or modified peptide, visual clarity alone is not sufficient. Analytical results are compared with a reference standard or the pre-reconstitution certificate of analysis.
Container selection matters because peptides can adsorb to glass, plastic, and filter membranes. Low-binding polypropylene tubes reduce losses for hydrophobic sequences, and filtration through a 0.22 µm membrane can remove particulates and microorganisms. Some peptides may bind to certain filter materials, so compatibility should be checked. Aliquots should be prepared before freezing to avoid repeated temperature cycling. Labels should record the peptide identity, lot number, solvent, concentration, reconstitution date, and storage condition.
In spite of 2018 election promises that "not a single person will lose their job" under his PC government, Ontario Health Minister Christine Elliot office announced in June 2019 that 416 workers would be laid off, as 20 health agencies, including 14 local health integration networks (LHINs), Cancer Care Ontario, eHealth Ontario were merged into one new super-agency called Ontario Health. With the merger "another 409 vacant positions will be eliminated." These changes are estimated to save "$350 million a year by 2021–22". A CBC News report said that the average wait times in Ontario hospitals set a new June record of an average of 16.3 hours waiting in emergency rooms in 2019, compared to 14.4 hours in June 2018, based on Health Quality Ontario data. More restructuring was announced by the Health ministry in September and no more job losses are anticipated. On November 18, 2024, Ford's government tabled a bill to ban supervised injection sites from operating within 200 meters of a school or child-care centre. The bill would also require municipalities to get approval from the provincial health minister and federal government before launching new facilities. In a news conference for the bill, Health Minister Sylvia Jones stated, "I want to be very clear, there will be no further safe injection sites in the province of Ontario under our government."
=== Precursor to other peroxide compounds === Hydrogen peroxide is a weak acid, forming hydroperoxide or peroxide salts with many metals. It also converts metal oxides into the corresponding peroxides. For example, upon treatment with hydrogen peroxide, chromic acid (CrO3 and H2SO4) forms a blue peroxide CrO(O2)2.
=== Reunion: 2007–present === The Jesus and Mary Chain reunited to perform at Coachella on 27 April 2007. During "Just Like Honey", Scarlett Johansson, who starred in the film Lost in Translation featuring the song, performed with the band on the main stage. The band held a warm-up gig the day before in Pomona, California with Giant Drag's Annie Hardy as the guest. The band's first UK performance since reforming was at the Meltdown festival in June. In June 2007, Jim Reid revealed that the band was working on a new album. In March 2008, the band released "All Things Must Pass" for the soundtrack to NBC's television series Heroes, their first new song since 1998. In September 2008, Rhino Records released the 4-CD compilation The Power of Negative Thinking: B-Sides & Rarities. In 2010, a greatest hits album, Upside Down: The Best of The Jesus and Mary Chain, was released via Music Club Deluxe. The band toured North America in 2012 and also played China for the first time in May. The lineup featured guitarist John Moore and Fountains of Wayne drummer Brian Young replacing Loz Colbert. Mark Crozer replaced Moore beginning with the band's Tel Aviv shows in October. In 2013, it was announced that a full-discography vinyl box set, dubbed as The Complete Vinyl Collection, would be released for the band's 30th anniversary, via Demon Music Group. In 2014, the band became the first to sign to the newly reformed Creation Management, helmed by Alan McGee. The band played Psychocandy in full through 2015 to celebrate the album's 30th anniversary.
Sources: en.wikipedia.org
=== Patent === Toward the end of January 1922, tensions mounted between the four "co-discoverers" of insulin and Collip briefly threatened to separately patent his purification process. John G. FitzGerald, director of the non-commercial public health institution Connaught Laboratories, therefore stepped in as peacemaker. The resulting agreement of 25 January 1922 established two key conditions: 1) that the collaborators would sign a contract agreeing not to take out a patent with a commercial pharmaceutical firm during an initial working period with Connaught; and 2) that no changes in research policy would be allowed unless first discussed among FitzGerald and the four collaborators. It helped contain disagreement and tied the research to Connaught's public mandate.
In Australia, diamorphine is listed as a schedule 9 prohibited substance under the Poisons Standard (October 2015). The state of Western Australia, in its Poisons Act 1964 (Reprint 6: amendments as at 10 September 2004), described a schedule 9 drug as: "Poisons that are drugs of abuse, the manufacture, possession, sale or use of which should be prohibited by law except for amounts which may be necessary for educational, experimental or research purposes conducted with the approval of the Governor."
== Honors and awards == Alfred Burger Award in Medicinal Chemistry, American Chemical Society, 1981 Thomas Alva Edison Patent Award, Research and Development Council, New Jersey, 1983 Ciba Award for Hypertension Research, American Heart Association, Council on High Blood Pressure Research, 1983 Chairman's Edward Robinson Squibb Award, E. R. Squibb & Sons, Inc., 1986 Award for Contributions to Medical Science, Pharmaceutical Manufacturers Association and National Health Council, 1988 Inventor of the Year Award, New Jersey Inventors Congress, 1988 Perkin Medal, Society of Chemical Industry, American Section, 1991 Warren Alpert Foundation Prize, Harvard Medical School, 1991 Award for Creative Invention, American Chemical Society, 1992 Herman Bloch Award for Scientific Excellence in Industry, University of Chicago, 1992 Lasker-DeBakey Clinical Medical Research Award, 1999
Bone mineral (also called inorganic bone phase, bone salt, or bone apatite) is the inorganic component of bone tissue. It gives bones their compressive strength. The main mineral in bone is calcium phosphate, with smaller amounts of hydrogen phosphate, carbonate, and hydroxide. Together these form carbonated hydroxyapatite with lower crystallinity, the predominant component of bone. Bone mineral is formed from globular and plate structures distributed among the collagen fibrils of bone and forming yet a larger structure. The bone salt and collagen fibers together constitute the extracellular matrix of bone tissue. Often the plural form "bone salts" is used; it reflects the notion of various salts that, on the level of molecular metabolism, can go into the formation of the hydroxyapatite. Bone mineral is dynamic in living animals; it is continually being resorbed and built anew in the bone remodeling process. In fact, the bones function as a bank or storehouse in which calcium can be continually withdrawn for use or deposited for storage, as dictated by homeostasis, which maintains the concentration of calcium ions in the blood serum within a particular range despite the variability of muscle tissue metabolism. Parathyroid hormone and calcitonin are the principal hormones with which the neuroendocrine system controls this ongoing process.
Sources: en.wikipedia.org
== Chemistry == Succimer is an isomer of 2,3-dimercaptosuccinic acid. 2,3-dimercaptosuccinic acid is the organosulfur compound with the formula HO2CCH(SH)CH(SH)CO2H. This colorless solid contains two carboxylic acid and two thiol groups, the latter being responsible for its mildly unpleasant odour. It occurs in two diastereomers, meso and the chiral dl forms. The 2,3-dimercaptosuccinic acid molecule has two stereocentres (two asymmetric carbon atoms), and can exist as three different stereoisomers. The 2S,3S and 2R,3R isomers are a pair of enantiomers, whereas the 2R,3S isomer (succimer) is a meso compound and thus optically inactive.
trace the evolution of a large number of organisms by measuring changes in their DNA, rather than through physical taxonomy or physiological observations alone, compare entire genomes, which permits the study of more complex evolutionary events, such as gene duplication, horizontal gene transfer, and the prediction of factors important in bacterial speciation, build complex computational population genetics models to predict the outcome of the system over time track and share information on an increasingly large number of species and organisms
or the total change of q from its generation or destruction inside the control volume. In a simple example, V could be a building, and q could be the number of living people in the building. The surface S would consist of the walls, doors, roof, and foundation of the building. Then the continuity equation states that the number of living people in the building (1) increases when living people enter the building (i.e., when there is an inward flux through the surface), (2) decreases when living people exit the building (i.e., when there is an outward flux through the surface), (3) increases when someone in the building gives birth to new life (i.e., when there is a positive time rate of change within the volume), and (4) decreases when someone in the building no longer lives (i.e., when there is a negative time rate of change within the volume). In conclusion, in this example there are four distinct ways that the net rate Σ may be altered.
Sources: en.wikipedia.org
Short-term storage is often at refrigerated temperatures, while longer storage may use freezing. Repeated freeze-thaw cycles are generally avoided because they can promote aggregation. Container material and headspace can also affect stability.
Mass spectrometry is commonly used to confirm molecular mass and detect modifications. Reversed-phase high-performance liquid chromatography can assess purity and separate related impurities. These methods are complementary rather than interchangeable.
Turbidity can indicate aggregation, precipitation, or microbial contamination. It may also result from incomplete dissolution or undissolved excipients. The cause is not identifiable from appearance alone.
Reconstitution means adding a liquid to a dried peptide to form a solution. The dried material is usually a lyophilized powder or cake produced by freeze-drying. The resulting liquid is a stock solution that can be diluted or analyzed further.